ADAM-Afatinib Diarrhea Assessment and Management

Clinical trial NCT01814553 · COMPLETED

Trial details

NCT number: NCT01814553
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2013-04-01
Primary completion: 2015-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.